Chronic Spontaneous Urticaria: Studying Age-Specific Therapies
Chronic spontaneous urticaria (CSU) presents differently in pediatric and adult populations. A retrospective analysis of 751 CSU patients (162 pediatrics and 589 adults) revealed shorter disease duration and lower angioedema rates in pediatric cases. Adults showed higher prevalence of anti-thyroid peroxidase positivity, elevated CRP, eosinopenia, and skin prick test reactivity. Pediatric patients exhibited better response to antihistamines, while only 7% used omalizumab compared to 20.8% in adults. The study highlights distinct clinical and treatment aspects in CSU between pediatric and adult cohorts.
Chronic urticaria (CU) is divided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), depending on eliciting factors. CU affects a significant portion of the population worldwide, with prevalence rates around 1.4%. The approach to CU treatment involves histamine-mediated symptom relief using antihistamines, often second-generation H1 antihistamines (sg-AH). Omalizumab and cyclosporine are considered for non-responsive cases. While guidelines exist, pediatric CU management lacks specific algorithms. Limited evidence-based knowledge on pediatric CU hinders clear guidance, especially regarding differences in clinical features, laboratory parameters, comorbidities, treatment response, and indicators compared to adults. This study addresses these gaps.
The study involved a retrospective analysis of patients diagnosed with chronic spontaneous urticaria (CSU) who sought treatment at the Pediatric Allergy Clinic and Dermatology Clinic of Istanbul Okmeydanı Training and Research Hospital between 2013 and 2019. The clinics were renowned centers for chronic spontaneous urticaria treatment and catered to a substantial number of outpatients. Referrals to the clinics were not contingent on treatment refractoriness or disease duration; all CSU patients were considered eligible for referral.
- Patients diagnosed with chronic spontaneous urticaria (CSU).
- Patients who sought treatment at the Pediatric Allergy Clinic and Dermatology Clinic of Istanbul Okmeydanı Training and Research Hospital between 2013 and 2019.
- Patients of all ages, including pediatric (<18 years), adolescent (12–17 years), and adult (≥18 years) patients.
- Patients who received treatment in accordance with the International Urticaria Guideline recommendations.
- Patients with available data on demographic features (age, gender, atopy, family history of atopy, disease duration, and angioedema) and laboratory values (serum eosinophil count, serum total IgE levels, C-reactive protein levels, antithyroid peroxidase antibody levels, IgG-anti-TPO positivity, skin prick test results, and autologous serum skin test results).
- Patients with chronic inducible urticaria or other types of urticaria.
- Patients seeking treatment for reasons other than chronic spontaneous urticaria.
- Patients with incomplete or insufficient medical records.
- Patients with a history of significant medical conditions that could confound the study results.
- Patients who did not receive treatment in accordance with the International Urticaria Guideline recommendations.
- Patients with missing data on key demographic features or laboratory values necessary for analysis.
The study was ethically approved by the Ethics Committee of Istanbul Okmeydanı Training and Research Hospital. Data on relevant patient characteristics and treatment responses were extracted from patient files. The analysis aimed to determine differences between pediatric, adolescent, and adult chronic spontaneous urticaria patients in terms of clinical features, laboratory parameters, comorbidities, and treatment response indicators.
The statistical analysis was conducted using the SPSS package program (Version 22 for Windows, SPSS Inc). Continuous variables’ suitability for normal distribution was assessed using the “Kolmogorov–Smirnov Test,” and the results were presented as a median along with the minimum and maximum values. Frequency data were presented as percentages (%). Gender, atopy, IgG-anti-TPO positivity, low IgE, elevated CRP, eosinopenia, ASST positivity, skin prick test positivity, and autoimmune thyroiditis rates were compared between groups using Pearson’s chi-squared test or Fisher’s exact test. For comparisons involving age, disease duration, and laboratory parameter levels, Kruskal–Wallis test (with Bonferroni correction) and Mann–Whitney U tests were employed.
To determine the factors influencing treatment responses for patients aged ≥12 years, binary logistic regression analysis was performed. The statistical significance level was established as p < .05. This rigorous analytical approach aimed to reveal meaningful differences, associations, and predictors within the studied parameters and treatment responses among the various patient groups.
A retrospective analysis of 751 CSU patients (162 pediatric and 589 adults) revealed distinct demographic and laboratory variations. Pediatric patients had a mean age of 10.7 ± 4.2, while adults had a mean age of 40.3 ± 13.8. Females accounted for 48.8% of pediatric patients and 69.6% of adult patients (p < .001). Disease duration was longer in adults (12 vs. 5 months), and angioedema was more prevalent (59.8% vs. 19.1%, p < .001). These trends persisted when analyzing age groups <12 years and ≥12 years
Autoimmune thyroiditis was more common in adults (9.4% vs. 3.4%, p = .02), and certain laboratory indicators exhibited age-associated differences. Specifically, IgG-anti-TPO positivity (24.7% vs. 9%, p < .001), elevated CRP (46.5% vs. 11.1%, p < .001), eosinopenia (38.5% vs. 18.1%, p < .001), and skin prick test positivity (39.3% vs. 28.8%, p = .03) were more frequent in adults. Conversely, low total IgE levels were more common in pediatric patients (29.5% vs. 17.5%, p = .004). Similar trends were observed in comparisons involving age subgroups.
Treatment and Refractoriness in Pediatric and Adult CSU Patients
Treatment distribution varied between pediatric and adult chronic spontaneous urticaria patients. In the pediatric group, standard H1-antihistamines were given to 57.3%, high doses of H1-antihistamines or combinations of H1-antihistamines and LTRA were administered to 33.9%, and omalizumab was used for 7%. Corresponding figures for adults were 40.1%, 25%, and 20.5%, respectively (p < .001). Similar treatment distributions were noted across different age groups.
Regarding refractoriness, only 8.6% of pediatric patients were unresponsive to first- and second-step treatments, while 35.0% of adults showed unresponsiveness. Indicators of refractoriness varied between pediatric and adult patients. For pediatric patients, eosinopenia (62.5% vs. 13.6%, p < .001), angioedema (46.7% vs. 19.4%, p = .01), and IgG-anti-TPO positivity (27.3% vs. 7.3%, p = .002) were associated with refractoriness. In adults, markers included angioedema (65.6% vs. 56.7%, p = .004) and eosinopenia (51.1% vs. 32%, p = .003). When focusing on ≥12 years of age, elevated CRP, angioedema, prick test positivity, and eosinopenia were linked to refractoriness. Logistic regression analysis demonstrated that prick test positivity negatively affected AH response in patients ≥12 years (beta = 0.23; B = -1.4, p = .02, 95% CI = 0.07–0.82). These findings provided insights into the differences in treatment response between pediatric and adult CSU patients.
This study highlights notable differences between pediatric and adult patients with chronic spontaneous urticaria (CSU) regarding clinical presentation, disease characteristics, associated conditions, laboratory findings, and treatment responses. An intriguing observation is the emergence of distinctive features in patients aged 12 and above, aligning adolescent chronic spontaneous urticaria with adult chronic spontaneous urticaria.
Female predominance in adult CSU patients (69.6%) contrasts with the less pronounced trend in pediatric cases (48.8%). This gender difference escalates with age, suggesting a potential hormonal influence on autoimmune and inflammatory processes. Angioedema, a marker of severe chronic spontaneous urticaria, is less prevalent in pediatric patients (19.1% vs. 59.8% in adults), with a rise by age (0–7 years: 8.9%, 8–11 years: 19.7%, 12–17 years: 26.8%). Angioedema correlates with antihistamine refractoriness in both pediatric and adolescent/adult groups.
Autoimmunity is increasingly recognized as a driver of CSU. Adult patients exhibit higher rates of autoimmune thyroiditis, IgG-anti-TPO positivity, eosinopenia, high CRP levels, and skin prick test positivity compared to pediatric patients. Conversely, low IgE levels are more frequent in pediatrics. Adolescent patients (12–17 years) exhibit increased IgG-anti-TPO positivity. Such findings suggest a possible type 2b autoimmune chronic spontaneous urticaria profile in adults, but further study is required to ascertain the pediatric endotype.
Treatment response patterns also vary. While pediatric chronic spontaneous urticaria responds well to standard antihistamine doses, adult cases often necessitate higher doses or alternate treatments. Omalizumab usage is less prevalent in pediatric cases (7% vs. 20.5% in adults). Response to standard antihistamines declines with age, with adolescents (12–17 years) requiring omalizumab treatment more frequently (17.9%).
Biomarkers linked to antihistamine refractoriness include eosinopenia, angioedema, IgG-anti-TPO positivity, elevated CRP, disease duration, and skin prick test positivity. These factors may guide treatment decisions. Notably, this study sheds light on distinct CSU profiles in pediatric and adult patients, suggesting evolving autoimmune mechanisms and potential hormonal contributions to disease pathogenesis. Further investigation is warranted to elucidate the intricate interplay of these factors across age groups in CSU patients.
Oncology Related Tools
- Prognostic Scoring for Myelofibrosis
- Opioid Conversion Calculator
- Updated Advanced Opioid Conversion Calculator
- Nonsteroidal anti-inflammatory drugs (NSAID) Selection Tool
- Absolute Neutrophil Count Calculator
- Body Surface Area (BSA) Multi-Calc
- Carboplatin AUC Calculator
- Carboplatin AUC – Updated Version
- Urinary Indices, Renal Failure Index (RFI) and Fractional Excretion of Sodium (FE-NA)
- Creatinine Clearance (CRCL) – Standard Calculator
- Creatinine Clearance Multi-Calc – All of the latest research
- Patient Controlled Analgesia (PCA) Settings
- Intravenous Antineoplastic Agents – Administration Guidelines
- Therapeutic Drug Levels
- Beers Criteria for potentially inappropriate medications
- Allergic response? 12-step desensitization protocol
- Protein requirements calculator
- Basal Metabolic Rate (BMR) Multi-calc (Estimate caloric requirements)
- Irritable Bowel Syndrome Treatment Options
- Common Anti-emetics
- Fall Assessment – Berg Balance Scale
- Levothyroxine Treatment In Patients With Thyroid Cancer
- Ocular Surgery In Infants And Post-Op Eye Drop Risks
- Cancer Care: Gender Bias In Decision-Making
- Respiratory Syncytial Virus Infection: A Tool For Assessing Clinical Severity
- Gynecologic Cancer Survivors: A Study Of Lifestyle Factors
- Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk
- Antithyroid Drug Therapy And Cardiovascular Morbidity
- Eosinophilic Dermatosis In Hematological Malignancy (EDHM): Case Study Reports
- Uterine Leiomyosarcoma: A-Meta Analysis Of Systemic Therapy Effectiveness
- Off-Label Medication Use In Oncology
- Monocytosis And Patient Risk Of Malignancy And Mortality
- Bedside Pediatric Early Warning System: A Validation Study
- Chronic Hyponatremia In Heart Failure
- Massage Therapy For Oncology Patient Pain
- Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
- Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy
- Acute Myeloid Leukemia And Diverse Patient Survival Outcomes
- Sarcopenia And Chronic Kidney Disease
- Childhood Obesity: Targeted Dietary Interventions
- Supragastric Belching And Acid Reflux Severity
- Diabetic Peripheral Neuropathy Diagnosis Using Nerve Ultrasonography
- IBD: A Link To Cancer And Infection
- Renal Transplant Risks With Prostate Cancer
- COPD Risk With Diabetes And Pre-Diabetes
- Urothelial Carcinoma – Uretal And Renal Pelvic Tumors
- Merkel Cell Carcinoma: A Case Of Metastasis To The Tonsils
- Infant Formula Protein Content And Childhood Obesity
- Maternal Migraines And Associated Pediatric Cancers
- Pediatric Neuroblastoma Diagnosis Using Urinary Catecholamine Metabolites
- Finerenone Therapy In CKD And Type 2 Diabetes
- Binge Eating Habits And Diabetic Implications
- Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases
- Melanoma Diagnosis Without Biopsy
- Pediatric Opioids And Pain Control In Fractures
- Daikenchuto Treatment For Chronic Constipation
- Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education
- Autistic Adults: A Study On Cognitive Therapy Experiences
- The Impact Of Long-Term Opioid Treatment On Endocrine Parameters
- Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis
- Diabetes Mellitus During The Pandemic
- Carfilzomib Therapy In Pediatric Acute Lymphoblastic Leukemia
- Golimumab Compliance In Long-Term Arthritis Treatment
- Medullary Thyroid Cancer And Vocal Cord Paralysis
- Primary Adenocarcinoma Of The Orbit: A Case Study
- Survival Trends: Pancreatic Cancer in the USA
- Nusinersen Therapy For Pediatric Spinal Muscular Atrophy
- Pediatric Liver Transplantation: A New Biological Abdominal Wall
- Influenza Surveillance: A Review Of Data Sources
- Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
- Dry Eye Disease And Dehydration
- Macular Edema Therapy Using Dexamethasone Nanoparticle Suspension
- Colorectal Cancer Screening For Older Adults
- Satiation And Satiety: An Overview And Clinical Calculator
- Cholesterol Screening To Aid In Glaucoma Detection
- Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors
- Olfactory Dysfunction and Screening For Depression: A QOL Study
- Cancer Diagnosis And Mental Health
- Mental Health Screening In Psoriatic Arthritis Patients
- Prostate Cancer: A New Biopsy Risk Calculator Using MRI
- Mental Health Study in Cancer Survivors
- Mental Health Screening In The Community
- Bone Mineral Density Screening Combined With Mammography
- Bone Mineral Density In Type 1 Diabetes Mellitus
- Cochlear Implants and Vestibular Screening
- Aprocitentan In Resistant Hypertension
- Predicting Cardiovascular Disease With Body Mass Index
- Obesity Screening To Predict Hot Flashes
- Hypertension Screening For Cardiovascular Health
- Dental Screening For Cardiovascular Disease Risk
- Blood Pressure and CVD Risk Reduction
- Lifestyle Changes For Hypoglycemia Prevention
- Ovarian Adenocarcinoma With Glaucoma: A Case Report
- Community Hypertension and Atherosclerosis Risk
- Thyroid Malignancy and Serum Calcitonin
- Rare Schwannoma In Lateral Nasal Wall
- Pyrotinib Therapy In HER2+ Breast Cancer
- Osteopenia Predicts Outcomes in Pancreatic Cancer
- Outcomes of Physical Exercise Regimens in Advanced Cancer
- Penile Squamous Cell Carcinoma And HPV
- Radiation Therapy And VTE Risk
- Pseudouveitis With Pancreatic Carcinoma: A Case Study
- Cancer Prevention In Rural Communities
- Skeletal Muscle Mass and Cancer Patient Quality of Life: A Meta-Analysis
- Incidence of Secondary Cancers After CIRT VS RT
- Filanesib Combination Therapy in Multiple Myeloma
- Pediatric Leukemia Patients Utilizing Levofloxacin
- Breast Cancer And An Analysis Of Cardiovascular Events
- Monotherapy Or Chemotherapy Adjunct: Pembrolizumab in Advanced NSCLC
- Advanced Gastric Cancer: Prognosis with Nivolumab Monotherapy
- Sinonasal B‐Cell Lymphomas A Cohort Study On Progression And Recurrence
- Platinum Resistant Recurrent Ovarian Cancer Treatment+/-Bevacizumab
- Metastatic Melanoma and Follow-Up MRI Scans
- Isatuximab Treatment in Refractory T-Acute Lymphoblastic Leukemia
- Ocular Melanoma and Treatment with Metformin
- Gastric Neuroendocrine Neoplasms
- Lung Cancer with Brain Metastasis After Late-Onset Bipolar Disorder: A Case Report
- Anlotinib with Camrelizumab in Lung Cancer Treatment
- Sebaceous Carcinoma Treatment Outcomes: A Multicenter Study
- Diffuse-Type Tenosynovial Giant Cell Tumors: Treatment and Progression
- Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report
- DNA Methylation Profiling in Sarcoma Classification
- Breast Tomosynthesis Simulator For Virtual Clinical Trials
- Renal Cell Carcinoma-Prognosis Via Albumin Levels
- Diagnostic Error Causing Cases of Cytopenia
- Hodgkin’s Lymphoma: A Case Study With Nystagmus and Diplopia
- Brugada Syndrome Treated with Lenalidomide: A Case Study
- Koolen-de Vries Case Study
- Suicidal Ideation and Somatic Treatments
- Study on Pavlovian Fear Conditioning and Fear Reversal in OCD
- Anxiety Scales in Lewy Body Disease
- Inoperable Locally Advanced Non-Small Cell Lung Cancer: Survival Rates of Endostar, CCRT
- Physician Practice Management and Private Equity
- Physician Spending And Its Association With Patient Outcomes
- Physician Burnout: Causes and Prevention
- LEAP-MS: Adaptations for Advanced Stages
- MS: Exercise Impacts on MRI
- The Role of Preretirement Job Complexity in Cognitive Performance
- Extrapontine Myelinolysis and PTA in Pregnancy
- Verbal Communication and Masks
- Sugammadex Versus Neostigmine in Thyroidectomy
- SGLT Inhibitors on Weight and Lipid Metabolism in Diabetes
- Saxagliptin: Obese Patients with Impaired Glucose Tolerance
- Levothyroxine Therapy and Depression
- Grave’s Disease and Risk of Systemic Lupus Erythematosus
- Benign Thyroid Removal and Patient Satisfaction
- MF- Biology, Management, and a Case Study of Ocular Manifestation
- Quality Of Life In Adolescent Cancer Survivors
- Cancer Opioid Risk Score
- Oncology-Specific Opioid Risk Calculator In Cancer Survivors
- 3D MRI for Non-invasive Ocular Proton Therapy of Uveal Melanomas
- Sexual Dysfunction in Prostate Cancer Patients
- 3-Day Surprise Question To Predict Survival Rates in Advanced Cancer Patients